Assessment of circulating Wnt1-inducible signaling pathway protein 1 (WISP1) in obesity and type 2 diabetes mellitus patients
Last updated: 03 Jan 2025
10.21608/aps.2018.18734
Adipokines, Obesity, Type 2 diabetes mellitus, WISP1
Nada
Habib
S.
Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
nada.salah@pharma.asu.edu.eg
Mohamed
EL-Hefnawy
H.
National Institute of Diabetes and Endocrinology (NIDE), Cairo, Egypt
dr_hefnawy@yahoo.com
Hala
El-Mesallamy
O.
Department of Biochemistry, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt
hala_elmosalamy@hotmail.com
2
1
2032
2018-01-01
2018-04-04
2018-06-01
47
53
2356-8380
2356-8399
https://aps.journals.ekb.eg/article_18734.html
https://aps.journals.ekb.eg/service?article_code=18734
6
Original Article
657
Journal
Archives of Pharmaceutical Sciences Ain Shams University
https://aps.journals.ekb.eg/
Assessment of circulating Wnt1-inducible signaling pathway protein 1 (WISP1) in obesity and type 2 diabetes mellitus patients
Details
Type
Article
Created At
22 Jan 2023